BOSTON - TelAve -- BOSTON, Massachusetts, United States

ClaraWell Inc. announces the launch of the first phase of its Common Symptom Screening Network, an initial set of five privacy-first tools covering flu, cough, headache, fever, and sore throat. The system enables structured exploration of symptoms without login, tracking, or data retention, helping individuals better understand their health through guided, non-diagnostic interactions.

The ClaraWell platform operates on a stateless architecture, meaning no personal health information is stored or retained across sessions. Users can access all tools without creating accounts, enabling immediate use while maintaining strict privacy boundaries.

Tools are deployed as standalone web applications, accessible directly in a browser with no downloads, installation, or account requirements.

More on TelAve News

• New Study Finds Americans Judge Vacations on Value, Not Price — Signaling a Permanent Shift in How Travel Gets Booked
• Pomona Organic Launches New Website, Surpasses 10 Million Bottles Sold, and Opens Affiliate Program to Creators
• Postmortem Pathology Opens Sacramento Office Offering Private Autopsies for Families and Healthcare Investigations
• Postmortem Pathology, a leading provider of private autopsies, has announced its expansion into the Las Vegas market
• Kick'em Out Quick® Evictions Announces a New Endorsed Eviction Attorney in Atlanta / Fulton County, GA

Each application guides users through a structured series of inputs to provide general context around symptom patterns, with the option to interact with ClaraWell through a conversational interface for further non-diagnostic exploration.

ClaraWell's system is built to ensure consistency, safety, and clarity across all interactions. A centralized control layer governs application behavior, enforcing structured outputs and clear boundaries aligned with healthcare compliance standards.

The platform emphasizes a calm, non-alarmist approach to symptom exploration, helping users understand when additional attention or professional consultation may be appropriate. All outputs are designed to support awareness and informed next steps, and support consideration of further clinical evaluation.

ClaraWell Inc. is a health technology company focused on building reliable, privacy-first systems for structured health interaction at scale. The company will continue expanding its network of symptom-focused applications through a controlled and measured rollout approach.

Learn more about ClaraWell at https://clarawellhealth.com